Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Conivaptan, a non-peptide inhibitor of antidiuretic hormone, was approved for hyponatremia caused by the syndrome of inappropriate antidiuretic hormone (SIADH), there is also some evidence that it may be effective in heart failure. Conivaptan inhibits subtype V1a and V2 of the vasopressin receptor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry |
Description | Conivaptan, a non-peptide inhibitor of antidiuretic hormone, was approved for hyponatremia caused by the syndrome of inappropriate antidiuretic hormone (SIADH), there is also some evidence that it may be effective in heart failure. Conivaptan inhibits subtype V1a and V2 of the vasopressin receptor. |
Synonyms | YM087, YM-087, YM 087, Vaprisol |
Molecular Weight | 498.5744 |
Formula | C32H26N4O2 |
CAS No. | 210101-16-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: Insoluble
DMSO: Soluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Conivaptan 210101-16-9 YM087 YM-087 YM 087 Vaprisol inhibitor inhibit